(Albany, US) DelveInsight has launched a new report on “Binge (Eating) Disorders – Market Insights, Epidemiology, and Market Forecast-2030” 

 

DelveInsight’s “Binge (Eating) Disorders – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Binge (Eating) Disorders, historical and forecasted epidemiology as well as the Binge (Eating) Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some of the facts:

• Binge eating disorder is seen among all age groups, races, and income levels, though it is most prevalent among women
• Binge eating disorder (BED) is actually the most common eating disorder in the United States.
• Binge eating disorder affects an estimated 2.8 million people in the United States.

 

Scope of the Report

• The report covers the descriptive overview of Binge (Eating) Disorders, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Binge (Eating) Disorders epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Binge (Eating) Disorders are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Binge (Eating) Disorders market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Binge (Eating) Disorders market

 

Request for free sample Report: https://www.delveinsight.com/sample-request/binge-eating-disorders-market

 

 

Binge-eating disorder is a serious eating disorder in which you frequently consume unusually large amounts of food and feel unable to stop eating.

Almost everyone overeats on occasion, such as having seconds or thirds of a holiday meal. But for some people, excessive overeating that feels out of control and becomes a regular occurrence crosses the line to binge-eating disorder.

When you have binge-eating disorder, you may be embarrassed about overeating and vow to stop. But you feel such a compulsion that you can’t resist the urges and continue binge eating. If you have binge-eating disorder, treatment can help.

Symptoms

Most people with binge-eating disorder are overweight or obese, but you may be at a normal weight. Behavioral and emotional signs and symptoms of binge-eating disorder include:

• Eating unusually large amounts of food in a specific amount of time, such as over a two-hour period
• Feeling that your eating behavior is out of control
• Eating even when you’re full or not hungry
• Eating rapidly during binge episodes
• Eating until you’re uncomfortably full
• Frequently eating alone or in secret
• Feeling depressed, disgusted, ashamed, guilty or upset about your eating
• Frequently dieting, possibly without weight loss

 

Request for free sample Report: https://www.delveinsight.com/sample-request/binge-eating-disorders-market

 

List of top key players in binge eating disorder drug market report are: –

● Roche

● Chronos Therapeutics

● Heptares

● Novo Nordisk

● Omeros Corp

● Sunovion Pharmaceuticals

● Opiant Pharmaceuticals 

 

Request for free sample Report: https://www.delveinsight.com/sample-request/binge-eating-disorders-market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Binge (Eating) Disorders

3. Competitive Intelligence Analysis for Binge (Eating) Disorders

4. Binge (Eating) Disorders: Market Overview at a Glance

4.1. Binge (Eating) Disorders Total Market Share (%) Distribution in 2017

4.2. Binge (Eating) Disorders Total Market Share (%) Distribution in 2030

5. Binge (Eating) Disorders: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Binge (Eating) Disorders Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Binge (Eating) Disorders Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Binge (Eating) Disorders Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Binge (Eating) Disorders Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Binge (Eating) Disorders Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Binge (Eating) Disorders Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Binge (Eating) Disorders Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Binge (Eating) Disorders Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Binge (Eating) Disorders Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Binge (Eating) Disorders Treatment and Management

8.2. Binge (Eating) Disorders Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Binge (Eating) Disorders Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Binge (Eating) Disorders: Seven Major Market Analysis

13.1. Key Findings

13.2. Binge (Eating) Disorders Market Size in 7MM

13.3. Binge (Eating) Disorders Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Binge (Eating) Disorders Total Market Size in the United States

15.1.2. Binge (Eating) Disorders Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Binge (Eating) Disorders Total Market Size in Germany

15.3.2. Binge (Eating) Disorders Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Binge (Eating) Disorders Total Market Size in France

15.4.2. Binge (Eating) Disorders Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Binge (Eating) Disorders Total Market Size in Italy

15.5.2. Binge (Eating) Disorders Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Binge (Eating) Disorders Total Market Size in Spain

15.6.2. Binge (Eating) Disorders Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Binge (Eating) Disorders Total Market Size in the United Kingdom

15.7.2. Binge (Eating) Disorders Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Binge (Eating) Disorders Total Market Size in Japan

15.8.3. Binge (Eating) Disorders Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Binge (Eating) Disorders

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/binge-eating-disorders-market?utm_source=Pressrelease&utm_medium=Pressrelease&utm_campaign=Pressrelease